Reuters: Regulatory News: BRIEF-GlaxoSmithKline seeks U.S. approval for melanoma drug combination

Changes are afoot at Blogtrottr! By popular request, we're bringing in paid plans with some cool new features (and more on the way). You can read all about it in our blog post.

Reuters: Regulatory News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

BRIEF-GlaxoSmithKline seeks U.S. approval for melanoma drug combination Jul 9th 2013, 06:06 LONDON, July 9 | Tue Jul 9, 2013 2:06am EDT LONDON, July 9 (Reuters) - GlaxoSmithKline Plc : * GSK announces U.S. submission for dabrafenib/trametinib combination in

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions